Indication

Primary cutaneous anaplastic large cell lymphoma

Primary cutaneous anaplastic large cell lymphoma is an indolent subtype of cutaneous T-cell lymphoma within the spectrum of primary cutaneous CD30-positive lymphoproliferative disorders. Read more about Primary cutaneous anaplastic large cell lymphoma

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Primary cutaneous anaplastic large cell lymphoma therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Primary cutaneous anaplastic large cell lymphoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Primary cutaneous anaplastic large cell lymphoma.

Primary cutaneous anaplastic large cell lymphoma is an indolent subtype of cutaneous T-cell lymphoma within the spectrum of primary cutaneous CD30-positive lymphoproliferative disorders.

It primarily affects the skin in adults, most commonly presenting in older individuals as solitary, clustered, or occasionally multifocal erythematous nodules, tumors, or ulcerated plaques.

Pathophysiologically, the condition is defined by diffuse dermal sheets of large atypical, pleomorphic, or anaplastic lymphoid cells strongly expressing the CD30 surface antigen, typically lacking anaplastic lymphoma kinase expression.

Despite its high-grade histopathological appearance, it generally follows a favorable clinical course with absence of extracutaneous dissemination at initial diagnosis, aside from possible regional lymph node involvement.

Personalize your experience

Follow Primary cutaneous anaplastic large cell lymphoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it